Weill Cornell Medicine in New York City will have new leadership sooner than planned, according to a Crain's New York Business report.
Laurie H. Glimcher, MD, announced in February she would be leaving Weill Cornell at the end of 2016 to serve as president and CEO of the Dana-Farber Cancer Institute in Boston. She will leave sooner, with physician-scientist Augustine M.K. Choi, MD, taking over as interim dean of Weill Cornell Medicine and interim provost for medical affairs of Ithaca, N.Y.-based Cornell University, effective June 1.
Dr. Glimcher will continue as an adviser at Weill Cornell Medicine through Aug. 31.
Dr. Choi, who joined the Weill Cornell Medicine faculty in 2013, is the Sanford I. Weill Chairman and Professor of Medicine in the Joan and Sanford I. Weill Department of Medicine. As chairman of the department of medicine and physician-in-chief at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, he leads an academic and clinical department that comprises 16 divisions and more than 1,700 faculty members, physicians and research scientists.
Jessica Bibliowicz, chairwoman of the Weill Cornell Board of Overseers, said Dr. Choi is ideally positioned to take on his new role with Weill Cornell Medicine as it moves forward.
"We are fortunate to have such a seasoned executive and physician-scientist step up to continue the institution's strong clinical, research and educational enterprises," she said in a prepared statement.
Ms. Bibliowicz and Cornell University President Emeritus Hunter Rawlings III, who will become the university's interim president April 25, will co-chair a search committee for the new dean and vice provost for medical affairs.
More articles on executive moves:
HackensackUMC names VP of clinical integration: 5 things to know
Lourdes Health System hires chief HR officer: 4 things to know
Tufts Medical Center names new CFO: 3 things to know